Accessibility Menu
 
PureTech Health Plc logo

PureTech Health Plc

(LSE) PRTC

Current Price$121.40
Market Cap$29.55B
Since IPO (2015)-32%
5 Year-71%
1 Year+18%
1 Month-3%

PureTech Health Plc Financials at a Glance

Market Cap

$29.55B

Revenue (TTM)

$6.35M

Net Income (TTM)

$31.79M

EPS (TTM)

$13.86

P/E Ratio

8.50

Dividend

$0.00

Beta (Volatility)

-0.11 (Low)

Price

$121.40

Volume

797,936

Open

$119.80

Previous Close

$121.40

Daily Range

$119.64 - $122.35

52-Week Range

$104.71 - $148.00

PRTC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PureTech Health Plc

Industry

Biotechnology

CEO

Bharatt M. Chowrira, PhD

Headquarters

Boston, MA 02210, US

PRTC Financials

Key Financial Metrics (TTM)

Gross Margin

3%

Operating Margin

-20%

Net Income Margin

9%

Return on Equity

15%

Return on Capital

-23%

Return on Assets

9%

Earnings Yield

11.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$29.55B

Shares Outstanding

243.42M

Volume

797.94K

Short Interest

0.00%

Avg. Volume

538.28K

Financials (TTM)

Gross Profit

$4.32M

Operating Income

$136.09M

EBITDA

$37.38M

Operating Cash Flow

$134.37M

Capital Expenditure

$11.00K

Free Cash Flow

$134.38M

Cash & ST Invst.

$367.31M

Total Debt

$159.14M

PureTech Health Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$1.85M

-41.2%

Gross Profit

$23.05M

+53.9%

Gross Margin

-12.45%

N/A

Market Cap

$29.55B

N/A

Market Cap/Employee

$369.39M

N/A

Employees

80

N/A

Net Income

$44.60M

-78.4%

EBITDA

$46.24M

+36.7%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$300.63M

-7.9%

Accounts Receivable

$13.86M

+502.5%

Inventory

$0.00

+100.0%

Long Term Debt

$12.93M

-35.3%

Short Term Debt

$7.99M

+43.2%

Return on Assets

9.16%

N/A

Return on Invested Capital

-22.94%

N/A

Free Cash Flow

$45.94M

+29.5%

Operating Cash Flow

$45.94M

+29.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AGY.LAllergy Therapeutics plc
$10.80+1.89%
AVCT.LAvacta Group Plc
$70.00-1.41%
NIOX.LNIOX Group Plc
$58.00+2.84%
BXP.LBeximco Pharmaceuticals Limited
$42.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About PRTC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.